1Nicolson GL, Irimura T, Nakajima M, et al. Metastatic cell attachment to and invasion and vascular endothelium and its underlying basal lamina using endothelial cell monolayers. Symp Fundam Cancer Res, 1983,36:145-167.
2Takaoka M, Naomoto Y, Ohkawa T, et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest, 2003,83 : 613-622.
3Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparan-ase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999,5: 793-802.
4Tang W, Nakamura Y, Tsujimoto M, et al. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol, 2002, 15:593-598.
7Zhang CX, Huang S, Xu N,et al. Phase Ⅱ study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer. Anticancer Drugs, 2007, 18: 581-586.
8Theodoro TR, de Matos LL, Sant Anna AV, et al. Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis. Neoplasia, 2007, 9 : 504-510.
9Shafat I, Barak AB, Postovsky S, et al. Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment. Neoplasia, 2007, 9: 909-916.
10Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest, 2001, 108: 341-347.
